Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

31.77

+0.62 (1.99%)

At close: Apr 14, 2026, 4:00 PM EDT

31.71

-0.06 (-0.19%)

After-hours: Apr 14, 2026, 7:54 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Revenue from Sale of Goods	14.61B	14.05B
Revenue from Sale of Goods Growth	3.95%	8.25%
Licensing Arrangements Revenue	678.00M	173.00M
Licensing Arrangements Revenue Growth	291.91%	-74.60%
Distribution Revenue	1.55B	1.58B
Distribution Revenue Growth	-1.59%	-2.42%
Other Segment Revenue	423.00M	745.00M
Other Segment Revenue Growth	-43.22%	30.70%
Revenue (Other)	1.00M	-
Revenue (Total)	17.26B	16.54B
Revenue (Total) Growth	4.32%	4.41%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States Revenue	9.19B	8.03B
United States Revenue Growth	14.34%	3.92%
Europe Revenue	5.04B	5.10B
Europe Revenue Growth	-1.23%	5.50%
International Markets Revenue	2.16B	2.46B
International Markets Revenue Growth	-12.22%	4.76%
Other Activities Revenue	870.00M	944.00M
Other Activities Revenue Growth	-7.84%	1.94%
Revenue (Other)	-	-
Revenue (Total)	17.26B	16.54B
Revenue (Total) Growth	4.32%	4.41%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States Segment Profit	3.36B	2.30B
United States Segment Profit Growth	46.17%	-4.09%
Europe Segment Profit	1.30B	1.58B
Europe Segment Profit Growth	-17.27%	6.56%
International Markets Segment Profit	336.00M	440.00M
International Markets Segment Profit Growth	-23.64%	-5.38%
Other Activities Segment Profit	-90.00M	18.00M
Other Activities Segment Profit Growth	-	-25.00%
Operating Income (Total)	2.16B	-303.00M
Operating Income (Total) Growth	-	-

Updated Jan 28, 2026. Data Source: Fiscal.ai.